ID   YBLi002-A
AC   CVCL_D0Q6
SY   YBL/IPSC02/CONTROL; YBL/IPSC002/CONTROL
DR   BioSamples; SAMEA112638603
DR   hPSCreg; YBLi002-A
DR   Wikidata; Q123033947
RX   PubMed=36905819;
CC   From: Yashraj Biotechnology Ltd; Navi Mumbai; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=36905819
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 17,19
ST   D19S433: 13,14
ST   D21S11: 32.2
ST   D2S1338: 18,20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 10,14
ST   FGA: 18,23
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
RX   PubMed=36905819; DOI=10.1016/j.scr.2023.103062;
RA   Chitrangi S., Vaity P., Jamdar A., Patel H., Bhatt S.;
RT   "Generation of human induced pluripotent stem cell line from PBMCs of
RT   healthy donors using integration-free Sendai virus technology.";
RL   Stem Cell Res. 69:103062-103062(2023).
//